Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
- PMID: 35646644
- PMCID: PMC9136391
- DOI: 10.3389/fonc.2022.913630
Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
Keywords: 77Lu-PSMA-I&T; ARv7; PSA; androgen receptor; mCRPC; molecular diagnosis; targeted therapy.
Conflict of interest statement
SB is one of the founders of Sanguine Diagnostics and Therapeutics, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Comment on
- Editorial on the Research Topic Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
References
-
- Muniyan S, Siddiqui JA, Batra SK. Therapeutic Options for Prostate Cancer: A Contemporary Update. In: Ponnusamy MPP, Batra SK, editors. Gene Regulation and Therapeutics for Cancer. New York: CRC Press; (2021). p. 328.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous